Dr. Pisters has been leading The University of Texas MD Anderson Cancer Center since 2017 and has been instrumental in guiding the institution through the COVID-19 pandemic, a national blood supply shortage, economic uncertainties, and tightening federal budgets. Under Dr. Pisters, MD Anderson has launched a multi-year strategy for accelerated facility expansion that aims to address patient access, technology needs, and market growth. He also acts as an advocate for Act for NIH, an initiative aiming to prioritize biomedical research funding on a national scale. Bolstered by his clinical background as a physician and surgeon, Dr. Pisters has a deep understanding of the patient journey and the need for health equity and improved quality of life at the population level. He has guided and participated in critical discussions at the local and national level that have impacted patient care, research, and funding. Recently, he led a discussion about AI in healthcare at the Richard Nixon’s National Cancer Conference. His influence extends seamlessly into the digital sphere, with his insights reaching 10,400 followers on LinkedIn alone. Dr. Pisters is on the board of directors for the Greater Houston Partnership and the CEO Roundtable on Cancer.
